| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 101190-62-9 | Naphthoquinomycin A | C40H47NO10 |
| 101191-83-7 | Laidlomycin phenylcarbamate | C44H67NO13 |
| 101192-00-1 | 1-Naphthyl Cyclohexylcarbamate | C17H19NO2 |
| 101192-30-7 | 1-Oxo-1H-benzo[c]quinolizine-2-carboxylic acid ethyl ester | C16H13NO3 |
| 101193-40-2 | Quinotolast | C17H12N6O3 |
| 101193-76-4 | 1,3-Dimethyl-4-(Methylamino)-2,5-Dioxo-4-Imidazolidinecarboxylic Acid | C7H11N3O4 |
| 101198-02-1 | 1-Dibenzylamino-2,3-Dichloropropane Hydrochloride | C17H20Cl3N |
| 101198-10-1 | 2-Bromoethyl-(2-Fluoroethyl)Azanium Chloride | C4H10BrClFN |
| 101199-38-6 | 10H-Phenothiazine-10-propanesulfonic acid sodium salt | C15H14NO3S2.Na |
| 101200-05-9 | Bis(pentamethylcyclopentadienyl)calcium | C20H30Ca |
| 101200-48-0 | Tribenuron methyl | C15H17N5O6S |
| 101200-51-5 | Disodium (3E)-7-amino-8-(2-carboxy-4-nitro-phenyl)diazenyl-3-[[2-methoxy-4-[3-methoxy-4-[(2Z)-2-(2-oxo-6-sulfonato-naphthalen-1-ylidene)hydrazinyl]phenyl]phenyl]hydrazinylidene]-4-oxo-naphthalene-2-sulfonate | C41H28N8Na2O14S2 |
| 101200-53-7 | 2-[3-(3-Chlorophenyl)Propyl]-Pyridine | C14H14ClN |
| 101203-31-0 | 3,3'-Bis(1,1-Dimethylethyl)-5,5',6,6'-Tetramethyl-[1,1'-Biphenyl]-2,2'-Diol | |
| 101204-49-3 | Diammonium 9-[2-deoxy-3,5-bis-O-(hydroxyphosphinato)pentofuranosyl]-N-methyl-9H-purin-6-amine | C11H23N7O9P2 |
| 101204-88-0 | 2-Methyl-3-(piperidinomethyl)pyrido(2,3-d)pyrimidin-4(3H)-one | C14H18N4O |
| 101205-02-1 | Cycloxydim | C17H27NO3S |
| 101208-17-7 | (3aR,4S,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(triphenylmethoxy)methyl]-2H-cyclopenta[b]furan-2-one | C34H30O5 |
| 101209-08-9 | 4'-Acetamido-3'-bromoacetophenone | C10H10BrNO2 |
| 101212-50-4 | 8-Aminoguanosine Triphosphate | C10H17N6O14P3 |
| 101212-53-7 | 6-N-Hydroxylaminopurine Deoxynucleoside Triphosphate | C10H16N5O13P3 |
| 101212-63-9 | Des-Trp(1)-Asp(5)-Leu(12)-Minigastrin | C70H91N15O26 |
| 101214-22-6 | N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-glutamic acid 5-(1,1-dimethylethyl) 1-(2,5-dioxo-1-pyrrolidinyl) ester | C28H30N2O8 |
| 101214-43-1 | [(1S)-2-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-2-oxo-1-(phenylmethyl)ethyl]carbamic acid 9H-fluoren-9-ylmethyl ester | C28H24N2O6 |
| 101216-59-5 | 12,14-Pentacosadiynoic Acid | C25H42O2 |
| 101219-16-3 | 4-(3-Methyl-1,3-Butadien-2-Yl)Morpholine | C9H15NO |
| 101219-61-8 | Picrasidine Q | C15H10N2O3 |
| 101219-68-5 | (R)-1-(4-Fluorophenyl)ethanol | C8H9FO |
| 101219-69-6 | (R)-1-(4-Cyanophenyl)ethanol | C9H9NO |
| 101219-71-0 | (S)-1-(4-Cyanophenyl)ethanol | C9H9NO |
| 101219-73-2 | (S)-1-(4-Fluorophenyl)ethanol | C8H9FO |
| 101221-46-9 | 2-(2-(N-(2-Hydroxyethyl)-N-Methyl)Aminoethyl)-1,4-Benzodioxan | C13H19NO3 |
| 101221-55-0 | 2-[1-[3-(Trifluoromethyl)Phenyl]Propan-2-Ylamino]Ethyl 4-Phenylbenzoate | C25H24F3NO2 |
| 101221-66-3 | 3-Hydroxy-4,4,4-trifluoro-3-trifluoromethylbutyrophenone azine | C22H16F12N2O2 |
| 101223-39-6 | (1S)-5-Oxobicyclo[2.2.1]Hept-2-Ene-7-Carboxylic Acid | C8H8O3 |
| 101224-22-0 | Buprenorphine beta-D-Glucuronide | C35H49NO10 |
| 101224-30-0 | 4-[(Trimethylsilyl)Methyl]Phenol | C10H16OSi |
| 101225-69-8 | (E)-1,2-Bis(2,6-Dimethylphenyl)Diazene 1,2-Dioxide | C16H18N2O2 |
| 101228-21-1 | (3E)-2-(Diphenylacetyl)-3-[(2E)-Ethylidenehydrazono]-1-Indanone | C25H20N2O2 |
| 101231-54-3 | 2-(Methoxycarbonyl)phenyl beta-D-glucopyranosiduronic acid methyl ester triacetate | C21H24O12 |
| 101233-12-9 | 19-37-alpha-Calcitonin gene-related peptide (human reduced) | C86H137N25O25 |
| 101234-67-7 | Diphenylmethyl (4-Oxo-1(4H)-Pyridinyl)Acetate | C20H17NO3 |
| 101234-68-8 | Benzhydryl 2-(2-Oxo-4-Thioxo-1-Pyridyl)Acetate | C20H17NO3S |
| 101234-73-5 | Octahydro-4H-Cyclopenta[b]Pyridin-4-One | C8H13NO |
| 101235-34-1 | 5'-Oleoyl Cytarabine | C27H45N3O6 |
| 101236-49-1 | Kushenol K | C26H32O8 |
| 101236-50-4 | Kushenol L | C25H28O7 |
| 101236-51-5 | Kushenol M | C30H36O7 |
| 101236-92-4 | 2-Ethyl-4-Nitro-1H-Benzimidazole | C9H9N3O2 |
| 101236-96-8 | 1-(4-Nitro-1H-Benzimidazol-2-Yl)Methanamine | C8H8N4O2 |